Prevalence of plasmid-mediated quinolone resistance - PubMed (original) (raw)
Prevalence of plasmid-mediated quinolone resistance
George A Jacoby et al. Antimicrob Agents Chemother. 2003 Feb.
Abstract
Quinolone resistance encoded by the qnr gene and mediated by plasmid pMG252 was discovered in a clinical strain of Klebsiella pneumoniae that was isolated in 1994 at the University of Alabama at Birmingham Medical Center. The gene codes for a protein that protects DNA gyrase from quinolone inhibition and that belongs to the pentapeptide repeat family of proteins. The prevalence of the gene has been investigated by using PCR with qnr-specific primers with a sample of more than 350 gram-negative strains that originated in 18 countries and 24 states in the United States and that included many strains with plasmid-mediated AmpC or extended spectrum beta-lactamase enzymes. qnr was found in isolates from the University of Alabama at Birmingham only during 6 months in 1994, despite the persistence of the gene for FOX-5 beta-lactamase, which is linked to qnr on pMG252. Isolates from other locations were negative for qnr. The prevalence of mcbG in the same sample was also examined. mcbG encodes another member of the pentapeptide repeat family and is involved in immunity to microcin B17, which, like quinolones, targets DNA gyrase. A single clinical isolate contained mcbG on a transmissible R plasmid. This plasmid and one carrying the complete microcin B17 operon slightly decreased sparfloxacin susceptibility but had a much less protective effect than pMG252. Plasmid-mediated quinolone resistance was thus rare in the sample examined.
Similar articles
- Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase.
Rodríguez-Martínez JM, Pascual A, García I, Martínez-Martínez L. Rodríguez-Martínez JM, et al. J Antimicrob Chemother. 2003 Oct;52(4):703-6. doi: 10.1093/jac/dkg388. Epub 2003 Sep 1. J Antimicrob Chemother. 2003. PMID: 12951342 - Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.
Wang M, Sahm DF, Jacoby GA, Hooper DC. Wang M, et al. Antimicrob Agents Chemother. 2004 Apr;48(4):1295-9. doi: 10.1128/AAC.48.4.1295-1299.2004. Antimicrob Agents Chemother. 2004. PMID: 15047532 Free PMC article. - Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J, Luo Y, Cui S, Wang W, Han L. Yang J, et al. Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12. Microb Drug Resist. 2011. PMID: 21563956 - Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms.
Li XZ. Li XZ. Int J Antimicrob Agents. 2005 Jun;25(6):453-63. doi: 10.1016/j.ijantimicag.2005.04.002. Int J Antimicrob Agents. 2005. PMID: 15890498 Review. - [Mechanisms of plasmid-mediated resistance to quinolones].
Rodríguez-Martínez JM. Rodríguez-Martínez JM. Enferm Infecc Microbiol Clin. 2005 Jan;23(1):25-31. doi: 10.1157/13070406. Enferm Infecc Microbiol Clin. 2005. PMID: 15701330 Review. Spanish.
Cited by
- Genomic characteristics of quinolone resistance in colistin-resistant Escherichia coli isolates from community residents in Ecuador and Vietnam.
Hoang HTT, Yamamoto M, Yamamoto Y. Hoang HTT, et al. JAC Antimicrob Resist. 2024 Sep 26;6(5):dlae151. doi: 10.1093/jacamr/dlae151. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39328887 Free PMC article. No abstract available. - Non-Canonical Aspects of Antibiotics and Antibiotic Resistance.
Amábile-Cuevas CF, Lund-Zaina S. Amábile-Cuevas CF, et al. Antibiotics (Basel). 2024 Jun 17;13(6):565. doi: 10.3390/antibiotics13060565. Antibiotics (Basel). 2024. PMID: 38927231 Free PMC article. Review. - Campylobacter jejuni and Campylobacter coli in human stool samples: antibiotic resistance profiles, putative virulence determinants and molecular characterization of the isolates.
Hizlisoy H, Sagiroglu P, Barel M, Dishan A, Gungor C, Koskeroglu K, Hizlisoy S, Atalay MA. Hizlisoy H, et al. World J Microbiol Biotechnol. 2023 Oct 24;39(12):353. doi: 10.1007/s11274-023-03786-y. World J Microbiol Biotechnol. 2023. PMID: 37874390 - Molecular Characterization and Antimicrobial Susceptibilities of Corynebacterium pseudotuberculosis Isolated from Caseous Lymphadenitis of Smallholder Sheep and Goats.
El Damaty HM, El-Demerdash AS, Abd El-Aziz NK, Yousef SG, Hefny AA, Abo Remela EM, Shaker A, Elsohaby I. El Damaty HM, et al. Animals (Basel). 2023 Jul 18;13(14):2337. doi: 10.3390/ani13142337. Animals (Basel). 2023. PMID: 37508114 Free PMC article. - Characterization of cephalosporin and fluoroquinolone resistant Enterobacterales from Irish farm waste by whole genome sequencing.
Prendergast DM, Slowey R, Burgess CM, Murphy D, Johnston D, Morris D, O' Doherty Á, Moriarty J, Gutierrez M. Prendergast DM, et al. Front Microbiol. 2023 Mar 22;14:1118264. doi: 10.3389/fmicb.2023.1118264. eCollection 2023. Front Microbiol. 2023. PMID: 37032887 Free PMC article.
References
- Ashraf, M. M., Z. U. Ahmed, and D. A. Sack. 1991. Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia. Can. J. Microbiol. 37:59-63. - PubMed
- Itokazu, G. S., J. P. Quinn, C. Bell-Dixon, F. M. Kahan, and R. A. Weinstein. 1996. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin. Infect. Dis. 23:779-784. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical